| Symbol | FEMY |
|---|---|
| Name | FEMASYS INC |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Surgical & Medical Instruments & Apparatus |
| Address | 3950 JOHNS CREEK COURT, SUWANEE, GA 30024 |
| Telephone | 770-500-3910 |
| Fax | — |
| — | |
| Website | https://www.femasys.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001339005 |
| Description | Femasys Inc is a biomedical company focused on transforming womens healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The companys mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Additional info from NASDAQ: |
- Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
Read moreFemasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
Read more- Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete
Read moreNew Form DEF 14A - FEMASYS INC <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001140361-26-018246 <b>Size:</b> 1 MB
Read moreNew Form ARS - FEMASYS INC <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001140361-26-018261 <b>Size:</b> 9 MB
Read moreNew Form DEFA14A - FEMASYS INC <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001140361-26-018255 <b>Size:</b> 933 KB
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT05977751 | Prospective Multi-Center Trial for FemBloc Permanent Birth Control | Na | Contraception | Recruiting | 2023-10-31 | 2031-06-01 | ClinicalTrials.gov |
| NCT04968847 | FemaSeed LOCAL Artificial Insemination Trial | Na | Infertility | Completed | 2021-07-15 | 2024-04-30 | ClinicalTrials.gov |
| NCT04273594 | FemBloc® Permanent Contraception - Confirmation Feasibility Trial | Na | Contraception | Active_Not_Recruiting | 2020-02-27 | 2027-04-01 | ClinicalTrials.gov |
| NCT03433911 | FemBloc® Permanent Contraception - Early Pivotal Trial | Na | Contraception | Completed | 2018-02-02 | 2025-02-10 | ClinicalTrials.gov |
| NCT03067272 | Pilot Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception | Na | Contraception | Completed | 2017-03-15 | 2023-03-14 | ClinicalTrials.gov |
| NCT01053052 | Study of FemVue(TM) Sono Tubal Evaluation System Method Comparison to HSG | Na | Fallopian Tube Patency Tests | Withdrawn | 2010-01-01 | 2013-01-01 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| FemBloc | Other | Approved | Contraception | ACTIVE_NOT_RECRUITING | NCT04273594 |
| Sonography with FemVue, and HSG | Other | Approved | Fallopian Tube Patency Tests | WITHDRAWN | NCT01053052 |
| FemBloc® Permanent Contraceptive System | Other | Approved | Contraception | COMPLETED | NCT03067272 |
| FemaSeed Localized Directional Insemination | Other | Approved | Infertility | COMPLETED | NCT04968847 |
| Laparoscopic bilateral tubal sterilization | Other | Approved | Contraception | COMPLETED | NCT03433911 |
| FemBloc | Other | Approved | Contraception | COMPLETED | NCT03433911 |
| FemBloc | Other | Approved | Contraception | RECRUITING | NCT05977751 |
| FemaSeed Localized Directional Insemination | DEVICE | Approved | Infertility | COMPLETED | NCT04968847 |
| Laparoscopic bilateral tubal sterilization | PROCEDURE | Approved | Contraception | COMPLETED | NCT03433911 |
| FemBloc | DEVICE | Approved | Contraception | RECRUITING | NCT05977751 |
| FemBloc® Permanent Contraceptive System | DEVICE | Approved | Contraception | COMPLETED | NCT03067272 |
| Sonography with FemVue, and HSG | DEVICE | Approved | Fallopian Tube Patency Tests | WITHDRAWN | NCT01053052 |